by Diana Copeland | Jun 30, 2020. Griffiths: J&J had spotted Actelion several years prior to the acquisition because of its great science and products in a disease area of high unmet need. Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass, allowing them to broaden their product range or branch into new therapy areas whilst extending their geographical reach. Jane Griffiths. Jane Griffiths biography. The straight-talking Brit is now the first female Company Group Chairman of Janssen in EMEA, the pharmaceutical division of the Johnson & Johnson family. Example: +water -Europe Until retiring in December 2019, Jane Griffith enjoyed a long career with Johnson & Johnson, during which she held executive roles in clinical research, international and strategic marketing, product management and operational management. Use a + to require a term in results and - to exclude terms. Connect with Jane Griffiths on LinkedIn. In the current, complex healthcare environment, key to the successful launch of any new pharmaceutical product or device is the ability to develop and implement an effective market access strategy. Completing her PhD in Biochemistry at the University of Aberystwyth, UK in 1982, Jane Griffiths has worked her way up the Johnson & Johnson career ladder, starting as a sales representative. Her career spanned a wide variety of functions including R&D, Pharmaceutical Strategy, Strategic Marketing and Market Access and Global … Scrip 100: Janssen's Jane Griffiths on job satisfaction at the top of pharma corporate ladder SCRIP Intelligence September 12, 2014 In this interview with SCRIP, I talked about the job satisfaction in my role, but also the challenges facing pharma today. Learn more about Janssen Pharmaceutical Companies of Johnson & Johnson PV: Why did J&J acquire Actelion? Dr. Jane Veronica Griffiths serves as Non-Executive Director of the Company. Today Griffiths is a stellar example of a senior female executive within pharma. Jane is an experienced leader with a successful track record in the healthcare industry. Jane Griffiths was guest speaker on corporate governance at a recent Cambridge Executive MBA dinner at Downing College, Cambridge. Jane is an experienced leader with a successful track record in the healthcare industry. View Jane's profile on the Johnson & Johnson website. Enclose phrases in quotes. Dr. Jane Griffiths is a non-executive director of Johnson Matthey Plc and a member of the board of directors of TB Alliance, a not-for-profit organisation dedicated to the discovery, development and delivery of better, faster acting and affordable tuberculosis drugs that are available to those who need them. Dr. Jane Griffiths is a non-executive director of Johnson Matthey Plc and a member of the board of directors of TB Alliance, a not-for-profit organisation dedicated to the discovery, development and delivery of better, faster acting and affordable tuberculosis drugs that are available to those who need them. Jane Griffiths Board Member, WRA Global. Jane Griffiths’ first position within Janssen was a sales role, from which she went on to undertake a wide range of roles across the business, gaining more and more momentum as she progressed. Learn more about the Cambridge Executive MBA. Jane Griffiths, Ph.D., Global Head of Actelion, discusses the process of integration post acquisition by Johnson & Johnson in November 2017.